Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 2,9813,000 of 20,252 grants

Active NON-SBIR/STTR RPGS
Self-Assembling Camptothecin Nanofiber Hydrogels as Adjunct Therapy for Intraoperative Treatment of Malignant Glioma
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2023 – 2028

Project summary Malignant gliomas, including the most common type glioblastoma (GBM), are histologically heterogeneous and invasive tumors known as the most devastating neoplasms w...

$5.21M
USD
Active NON-SBIR/STTR RPGS
The role for phase separation in oncogenesis and aberrant chromatin looping formation
NATIONAL CANCER INSTITUTE Duke University United States 2023 – 2027

PROJECT SUMMARY/ABSTRACT Rearrangement of NUP98 gene (NUP98-r) is recurrent in leukemias such as acute myeloid leukemia (AML). Patients with NUP98-r show poor prognosis and therapy...

$5.73M
USD
Active NON-SBIR/STTR RPGS
The role for phase separation in oncogenesis and aberrant chromatin looping formation
NATIONAL CANCER INSTITUTE Duke University United States 2023 – 2027

PROJECT SUMMARY/ABSTRACT Rearrangement of NUP98 gene (NUP98-r) is recurrent in leukemias such as acute myeloid leukemia (AML). Patients with NUP98-r show poor prognosis and therapy...

$5.49M
USD
Active NON-SBIR/STTR RPGS
Self-Assembling Camptothecin Nanofiber Hydrogels as Adjunct Therapy for Intraoperative Treatment of Malignant Glioma
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2023 – 2028

Project summary Malignant gliomas, including the most common type glioblastoma (GBM), are histologically heterogeneous and invasive tumors known as the most devastating neoplasms w...

$5.03M
USD
Active NON-SBIR/STTR RPGS
NCI Clinical Trial Research Strategy, Harnessing of Equity, and Implementation
NATIONAL CANCER INSTITUTE University of California, San Diego United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT I am a female board-certified radiation oncologist and Professor at the University of California (UC), San Diego, in the Department of Radiation Medicine....

$1.74M
USD
Active TRAINING, INSTITUTIONAL
Dartmouth Training Program in Quantitative Cancer Research
NATIONAL CANCER INSTITUTE Dartmouth College United States 2023 – 2028

ABSTRACT Continued support is requested for a multidisciplinary Dartmouth Training Program in Quantitative Cancer Research (TQCR). The TQCR Program seeks to provide cross-training...

$2.14M
USD
Active NON-SBIR/STTR RPGS
Cognitive aging in long-term breast cancer survivors
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2023 – 2028

ABSTRACT Despite significant progress in understanding cognitive change associated with cancer and cancer treatments, little is known regarding longer-term cognitive outcomes over...

$7.31M
USD
Active OTHER RESEARCH-RELATED
Examining the Role of RNF168 Activity in BRCA1 Mutant Cancers
NATIONAL CANCER INSTITUTE Washington University United States 2023 – 2026

PROJECT SUMMARY/ABSTRACT My career goal is to develop an independent research program focused on DNA damage signaling and how it can be exploited for the treatment of cancer. The w...

$1.52M
USD
Active OTHER RESEARCH-RELATED
The role of stem-like CD8 T-cells in the abscopal response
NATIONAL CANCER INSTITUTE Emory University United States 2023 – 2028

PROJECT SUMMARY Prognosis is poor for patients diagnosed with locally advanced melanoma. Survival outcomes are improved with checkpoint blockade in the neoadjuvant, adjuvant and un...

$2.42M
USD
Active OTHER RESEARCH-RELATED
Mechanisms and strategies to rescue suboptimal T cell priming in colon cancer
NATIONAL CANCER INSTITUTE Cold Spring Harbor Laboratory United States 2023 – 2026

PROJECT SUMMARY/ABSTRACT I propose to functionally interrogate mechanisms of cancer immune evasion and immunotherapy resistance in powerful new mouse models of colorectal cancer (C...

$2.01M
USD
Active OTHER RESEARCH-RELATED
Design and implementation of a social cognitive theory-based medication adherence coaching intervention
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2023 – 2028

ABSTRACTDr. Benyam Muluneh’s long-term career goal is to become a leading clinician-researcher in oncology by leveraging health behavior theories and implementation science methods...

$1.94M
USD
Completed OTHER RESEARCH-RELATED
Targeting regenerative reprogramming in colorectal cancer
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2023 – 2024

ABSTRACT Poorly defined fitness features enable a subset of cancer cells to survive therapy, ultimately giving rise to treatment-refractory tumors. The expanded use of sequencing t...

$2.93M
USD
Active NON-SBIR/STTR RPGS
Metabolism of cancer chemotherapeutics by the human gut microbiome
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2023 – 2028

PROJECT SUMMARY Rigorous data from our lab and others indicate that the gut microbiome may an underappreciated contributor to inter-individual variations in cancer drug efficacy an...

$6.03M
USD
Active NON-SBIR/STTR RPGS
Transcriptional Regulation of Dormancy and Emergence in Breast Cancer
NATIONAL CANCER INSTITUTE University of Pittsburgh At Pittsburgh United States 2023 – 2028

Breast cancer ranks second among cancer deaths in women in the United States. Breast cancer-related mortality primarily results from metastatic growth of disseminated cells. While...

$4.01M
USD
Active NON-SBIR/STTR RPGS
Modeling the equity impact of age restricted in-person location policies for youth tobacco use
NATIONAL CANCER INSTITUTE Ohio State University United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT This proposal concerns age restricted in-person location policies (ARLPs), a novel tobacco control strategy that could have a critical impact on reducing y...

$6.74M
USD
Active NON-SBIR/STTR RPGS
Targeting Senescence to Mitigate Chemotherapy-induced Functional Decline
NATIONAL CANCER INSTITUTE University of California Los Angeles United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT Advances in breast cancer treatment have resulted in significant survival gains. However, cure or control of breast cancer is not necessarily accompanied b...

$7.01M
USD
Active TRAINING, INDIVIDUAL
Role of hypoxia in CD8+ T cell exclusion and suppression in pancreatic cancer
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2023 – 2027

PROJECT SUMMARY Pancreatic ductal adenocarcinoma (PDAC) is a deadly malignancy characterized by poor response to all existing therapies. Although immunotherapy has shown great prom...

$403.8K
USD
Completed TRAINING, INDIVIDUAL
Differentiation-focused CRISPR Screen identifies LSD1 and Menin as combination therapy targets that induce terminal differentiation in AML
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2023 – 2025

Project Summary Acute myeloid leukemia (AML) is a lethal blood cancer characterized by a differentiation “block” that prevents myeloid progenitor maturation resulting in uncontroll...

$476.9K
USD
Completed TRAINING, INDIVIDUAL
Uncovering ATR signaling networks underlying chemotherapeutic synergies
NATIONAL CANCER INSTITUTE Cornell University United States 2023 – 2025

PROJECT SUMMARY/ABSTRACT The DNA damage sensor kinase ATR is essential for human cell viability and plays a crucial role in cell tolerance to DNA replication stress1–3. Cancer cell...

$441.7K
USD
Completed TRAINING, INDIVIDUAL
New Hardware and Software Developments for Improving Prostate Metabolic MR Imaging
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2023 – 2025

Project Summary/Abstract The proposed F31 NRSA Predoctoral Fellowship to Promote Diversity in Health-Related Research project aims to develop new MR detector hardware and acquisiti...

$402.1K
USD